December 2, 2016: Gilead is a cash-generating machine, bringing in $13.2B in free cash flow from operations so far this year, which allowed the biotech to close two deals. A deal to gain access to Galapagos' JAK1-selective inhibitor filgotinib for inflammatory disease indications for $725M...
December 2, 2016: Theranos is cleaning house once again, but this time the company is making changes to its leadership. In January, Theranos will disband its board of counselors as part of an ongoing evolution and consolidation.
December 2, 2016: Boehringer Ingelheim announced yesterday that it was restructuring, and was cutting another 180 jobs in Connecticut. Beginning in July, the company planned to cut its U.S. workforce by 244 people.
December 2, 2016: Intellia held a ribbon-cutting ceremony yesterday for its new laboratory facilities. The new labs are at 40 Erie Street in Cambridge.